Politics
Saraki attends launch of Trump’s Africa Strategy in US
The President of the Senate, Dr. Abubakar Bukola Saraki, is set to attend the launch of the United States of America (U.S) President, Donald J. Trump’s, Strategy for Africa, which will be unveiled to the public on Thursday, December 13, 2018.
Special Adviser to the President of the Senate on Media and Publicity, Yusuph Olaniyonu, in a statement, explained that the new United States strategy provides for more effective utilization of existing U.S. resources on the African continent.
The Trump plan, according to U.S. Assistant Secretary of State for the Bureau of African Affairs, Tibor P. Nagy, Jr, will focus on bringing more foreign direct investment into Africa and is in line with the Legislative Agenda of the 8th National Assembly which is aimed at reforming the Nigerian economy through strategic legislation that will help promote increased participation of private sector actors.
Other members of the Senate President’s delegation include Senator Ben Bruce, Vice Chairman of the Senate Committee on Media and Public Affairs; Senator Monsurat Sunmonu, Chairman of the Senate Committee on Foreign Affairs; and Honourable Nnenna Ukeje, Chairman of the House of Representatives Committee on Foreign Affairs.
-
Football6 days agoBallon d’Or 2026: Yamal, Mbappe, Kane emerge early favourites
-
Football5 days agoPost-World Cup Shake-Up: Managerial changes, record transfers dominate football headlines
-
Football5 days agoWAFCON 2026: Super Falcons target winning start as Nigeria face debutants Malawi
-
Energy4 days agoNigeria wastes enough gas to Ggenerate 62,400GWh of electricity amid deepening energy crisis — NOSDRA
-
Latest1 week agoAccountability group questions ₦962.8bn Allocation for empowerment projects, official vehicles in 2026 budget
-
Business2 days agoCooking gas dealers slash prices amid intensifying market competition
-
Business1 day agoInformation Minister, VON DG to lead ARCON’s 2026 Advertising Industry Colloquium
-
Health5 days agoFauci’s personal diaries fuel renewed scrutiny of COVID-19 vaccine safety


